AzTrials
AzTrials

Down SyndromeNCT04754178

Assessment of Skills and Behaviors in Children With Down Syndrome

An observational study of Down Syndrome, run by Universidad de Granada at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Parents of children with Down Syndrome can help in describing children's abilities and behavior. Most of the studies evaluating parents of children with Down Syndrome and other intellectual disabilities have focused on parental stress and coping; Additionally, most research has evaluated the perspectives of mothers… Read more about this study

Who is it for?
Ages 0 to 3 years
Conditions the study is for
Down Syndrome
How many people
60 participants
Where
1 siteSpain
Study dates
15 Feb 2021to 15 May 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 3 years
  • All sexes
  • Child

Study population: Patients with Down Syndrome

Who may be able to join

  • Down syndrome childrens
  • Age between 0 and 3 years

Who cannot join

  • Other physical or functional impairment that limits the performance of evaluation

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Faculty of Healthy Sciences

    Granada, 18016

Other trials in Spain

About this study

Parents of children with Down Syndrome can help in describing children's abilities and behavior. Most of the studies evaluating parents of children with Down Syndrome and other intellectual disabilities have focused on parental stress and coping; Additionally, most research has evaluated the perspectives of mothers rather than fathers. For this reason, in this study we aims to evaluate skills and behaviors in children with Down syndrome through the perception of parents.

Conditions
Down Syndrome
Medical subject headings
Down Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04754178
Study groupRoleWhat they receive
Down syndromeDown syndrome patients and their parents
Control groupHealthy children and their parents

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Early Motor Questionnaire

    The EMQ is designed as a fast and easy to complete motor questionnaire, and is organized into 3 sections: Gross motor skills, fine motor skills, and perception-action integration skills. The EMQ is not a standardized assessment, but can be used in research settings, serve as a motor screener, or as complement to standardized measures of early motor development.

    Measured: Baseline

  2. Montreal's children's Hospital Feeding Scale

    The Montreal Children's Hospital Feeding Scale (MCHFS) is a quick and reliable measure of feeding problems for clinical settings, but there is little examination of its relationship to commonly used research measures of parental feeding practice, child eating behaviour and observations of parent-infant interaction at mealtimes.

    Measured: Baseline

  3. Feeding Hándicap Índex Children

    y the Feeding Handicap Index (FHI), [20] was developed and standardized on typically developing children, children with CP, Autism spectrum disorder in the age range of 2-10 years and Intellectual disability. FHI has 38 items related to statements related to physical (21), emotional (12) and functional (5) aspects of feeding and swallowing abilities. It has a 3 point rating scale (0, 1 \& 2) where "0" indicates the individual "Never has this problem", "1" indicates "Sometimes has this problem" and "3" indicates "Always has this problem"

    Measured: Baseline

  4. Parent Perceptions of Physical Activity Scale

    Evaluate the Parent Perceptions of Physical Activity in Families of Toddlers With Neurodevelopmental Disorders

    Measured: Baseline

  5. Bayley Scales of Infant and Toddler Development

    is an individually administered scale that assesses five key developmental domains in children between 1-42 months of age: cognition, language (receptive and expressive communication), motor (gross and fine), social-emotional and adaptive behavior. The first three are assessed through direct observation of the child in test situations, while the last two are assessed through questionnaires to be completed by the main caregiver.

    Measured: Baseline

  6. Early Clinical Assessment of Balance

    The Early Clinical Assessment of Balance (ECAB) is a measure of postural stability for children.

    Measured: Baseline

  7. Infant Positioning Assessment Tool

    The Infant Position AssessmentTool (IPAT) is a six-item tool with cumulative scores ranging from 0 to 12. It was developed as a teaching tool to standardize developmentally supportive positioning practices in the NICU and provides a method for evaluation of those positioning practices.

    Measured: Baseline

  8. Asymmetry

    Asymmetry was evaluated with photography

    Measured: Baseline

  9. COMFORT behaviour scale

    The COMFORT behaviour scale (COMFORT-B scale) is widely used in paediatric intensive care units to assess young children's pain and distress.

    Measured: Baseline

  10. Segmental Assessment of Trunk Control

    The SATCo i,ii is a validated outcome measure that identifies at which head/trunk segment Targeted Training should commence. The SATCo determines the topmost (most cephalo) segment at which control of the upright posture is poor or not demonstrated i.e. is currently being learned for each of static, active and reactive control.

    Measured: Baseline

Secondary outcomes (6)
  1. EuroQol-5D

    The perception of the level of health and the quality of life were evaluated with the questionnaire European Quality of

    Life-5 Dimensions (EQ-5D). It is composed of 2 parts in which health status is assessed:

    • Descriptive system: It consists on 5 dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Patients classify their health status in 3 severity levels: having no problems, having some or moderate problems, being unable to do/having extreme problems.
    • Visual Analog Scale, by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status)

    Measured: Baseline

  2. Hospital Anxiety and Depression Scale

    Anxiety and depression will be assessed with the Hospital Anxiety and Depression Scale (HADS) . This scale is composed of 14 items divided into two subscales, 7 items of anxiety and 7 items of depression, involving higher values worse psycho-emotional state

    Measured: Baseline

  3. Zarit Burden Interview

    The Zarit Burden Interview, is a popular caregiver self-report measure used by many aging agencies. Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always).

    Measured: Baseline

  4. International physical activity questionnaire

    The International Physical Activity Questionnaire (IPAQ) was developed to measure health-related physical activity (PA) in populations.

    Measured: Baseline

  5. Charlson comorbidity index

    Charlson Comorbidity Index predicts the ten-year mortality for a patient who may have a range of comorbid conditions

    Measured: Baseline

  6. Brief Infant Sleep Questionnaire

    The Brief Infant Sleep Questionnaire (BISQ) is used to assess sleep patterns, parent perception, and sleep-related behaviors in young children (0-36 months). The BISQ has been validated against actigraphy, daily logs, and has high sensitivity in documenting expected developmental trends in sleep

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2021
  2. Study start15 Feb 2021 (estimated)
  3. Primary completion15 Apr 2021 (estimated)
  4. Study completion15 May 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04754178
Sponsor's protocol ID
DF0093UG
Status last verified
Feb 2021
First submitted
11 Feb 2021
Last updated
15 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Down Syndrome, run by Universidad de Granada at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Early Motor Questionnaire (time frame: Baseline). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04754178 | AzTrials